Security Snapshot

ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (ABEO) Institutional Ownership

CUSIP: 00289Y206

13F Institutional Holders and Ownership History from Q2 2022 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

102

Shares (Excl. Options)

38,934,060

Price

$5.27

Type / Class
Equity / Common Stock, par value $0.01
Symbol
ABEO on Nasdaq
Shares outstanding
56,742,057
Price per share
$4.53
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
38,934,060
Total reported value
$205,157,125
% of total 13F portfolios
0%
Share change
+3,345,661
Value change
+$17,587,157
Number of holders
102
Price from insider filings
$4.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • ABEO - ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 is tracked under CUSIP 00289Y206.
  • 102 institutions reported positions in Q4 2025.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 102 to 2 between Q4 2025 and Q1 2026.
  • Reported value moved from $205,157,125 to $6,902.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Form 13F

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP 00289Y206?
CUSIP 00289Y206 identifies ABEO - ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (ABEO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 10% 0% $27,327,316 +$988,597 5,184,662 +3.8% Nantahala Capital Management, LLC 30 Sep 2025
Funicular Funds, LP 5.3% $14,916,352 3,007,329 Funicular Funds, LP 27 Mar 2026
BlackRock, Inc. 5.8% $16,751,808 2,949,262 BlackRock, Inc. 30 Jun 2025
Kaufman Daniel Louis 5.2% $15,306,871 2,943,629 Daniel Kaufman 26 Mar 2026
James Russell Revocable Trust 5.3% $18,774,038 2,720,875 James Russell Revocable Trust 16 Sep 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 5.2% $15,627,840 2,676,000 Suvretta Capital Management, LLC 30 Jun 2025
Nantahala Capital Partners Limited Partnership 5.1% $13,801,390 2,618,462 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 29 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC 1.7% $4,292,820 809,966 Millennium Management LLC 31 Mar 2025

As of 31 Dec 2025, 102 institutional investors reported holding 38,934,060 shares of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (ABEO). This represents 69% of the company’s total 56,742,057 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (ABEO) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 8.7% 4,963,052 +8.7% 1.6% $26,155,284
BlackRock, Inc. 5.6% 3,159,863 +0.4% 0% $16,652,478
VANGUARD GROUP INC 4.9% 2,757,143 +5.9% 0% $14,530,144
SUVRETTA CAPITAL MANAGEMENT, LLC 4.7% 2,676,000 0% 0.35% $14,102,520
Cable Car Capital, LP 4.4% 2,500,000 +317% 0.82% $13,175,000
AIGH Capital Management LLC 3.5% 2,000,000 3.1% $10,540,000
Vivo Capital, LLC 3.2% 1,842,751 0% 0.63% $9,711,298
GEODE CAPITAL MANAGEMENT, LLC 2% 1,137,127 +0.89% 0% $5,993,872
KENNEDY CAPITAL MANAGEMENT LLC 1.9% 1,050,095 -0.07% 0.12% $5,534,001
TANG CAPITAL MANAGEMENT LLC 1.8% 1,000,000 0.26% $5,270,000
NAN FUNG TRINITY (HK) LTD 1.7% 956,770 +71% 0.4% $5,042,178
STATE STREET CORP 1.6% 898,438 +25% 0% $4,734,768
Propel Bio Management, LLC 1.5% 830,780 -15% 3.7% $4,378,211
AWM Investment Company, Inc. 1.4% 774,130 +42% 0.39% $4,079,665
683 Capital Management, LLC 1.4% 770,000 0% 0.34% $4,057,900
Stonepine Capital Management, LLC 1.3% 709,505 +57% 3% $3,739,091
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1.2% 701,288 0.01% $3,695,788
Diametric Capital, LP 1.2% 694,421 +301% 0.98% $3,659,598
SILVERARC CAPITAL MANAGEMENT, LLC 1.1% 627,738 -37% 0.48% $3,308,179
Aberdeen Group plc 1.1% 616,413 0.01% $3,248,497
Balyasny Asset Management L.P. 1% 591,737 0.01% $3,118,454
CITIGROUP INC 0.92% 521,087 -0.55% 0% $2,746,129
BANK OF AMERICA CORP /DE/ 0.89% 507,625 -44% 0% $2,675,184
GOLDMAN SACHS GROUP INC 0.89% 502,184 +56% 0% $2,646,509
Simplify Asset Management Inc. 0.88% 500,342 -11% 0.04% $2,636,802

Institutional Holders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 (ABEO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,527 $6,902 -$3,227 $4.53 2
2025 Q4 38,934,060 $205,157,125 +$17,587,157 $5.27 102
2025 Q3 35,587,405 $187,905,228 +$3,962,019 $5.28 99
2025 Q2 34,902,859 $198,249,797 +$32,047,638 $5.68 95
2025 Q1 29,672,466 $141,241,182 -$4,440,489 $4.76 70
2024 Q4 30,594,457 $170,412,284 +$10,328,621 $5.57 62
2024 Q3 28,750,213 $181,703,500 -$8,991,871 $6.32 54
2024 Q2 30,142,466 $127,804,658 +$64,543,759 $4.24 47
2024 Q1 14,448,596 $104,749,937 +$6,931,452 $7.25 55
2023 Q4 14,140,688 $70,843,546 +$8,490,638 $5.01 48
2023 Q3 12,477,026 $52,529,560 +$13,131,838 $4.21 38
2023 Q2 9,392,092 $37,850,403 +$7,730,751 $4.03 36
2023 Q1 7,525,889 $21,222,791 -$5,713,208 $2.82 33
2022 Q4 7,901,310 $24,332,329 +$21,133,266 $3.08 38
2022 Q3 1,039,522 $3,159,012 +$3,053,000 $3.04 19
2022 Q2 34,773 $169,000 +$169,000 $4.86 1

Sponsored